NEOPLASMS, ENDOMETRIAL
Clinical trials for NEOPLASMS, ENDOMETRIAL explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, ENDOMETRIAL trials appear
Sign up with your email to follow new studies for NEOPLASMS, ENDOMETRIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for endometrial cancer: Mo-Rez drug faces chemo in major trial
Disease control Recruiting nowThis large Phase 3 study tests a new drug called mocertatug rezetecan (Mo-Rez) against standard chemotherapy for people with endometrial cancer that has progressed after platinum-based chemo and immunotherapy. About 600 participants will be randomly assigned to receive either Mo-…
Matched conditions: NEOPLASMS, ENDOMETRIAL
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Immunotherapy plus chemo shows promise for tough uterine cancer
Disease control Recruiting nowThis phase 2 trial is testing whether the immunotherapy drug dostarlimab, given together with standard chemotherapy (carboplatin and paclitaxel), can help Chinese patients with a specific genetic type of advanced or recurrent endometrial cancer. The study will enroll 30 participa…
Matched conditions: NEOPLASMS, ENDOMETRIAL
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC